425: Ansys Addresses Stockholder Demands with Supplemental Proxy Statement Disclosure Amidst Synopsys Merger

Sentiment:

425 Filing


Ansys voluntarily supplements its proxy statement with additional disclosures to address stockholder demands challenging the adequacy of information related to the proposed merger with Synopsys.

Summary

  • Ansys has received fourteen demand letters from stockholders challenging the adequacy of disclosures in the proxy statement related to the proposed merger with Synopsys.
  • To avoid potential litigation and provide additional information, Ansys is voluntarily supplementing the proxy statement.
  • The supplemental disclosures include details regarding post-closing employment and equity arrangements for Ansys executive officers, clarifying that no substantive discussions or agreements were in place at the time of the merger agreement.
  • Dr. Ajei Gopal, President and CEO of Ansys, is expected to become a member of the Synopsys board of directors upon completion of the merger, subject to Synopsys' director nomination process.
  • The supplemental information also updates the financial analysis by Qatalyst Partners, including adjustments for Ansys' outstanding debt and a revised table of comparable transactions with enterprise values.
  • Ansys reaffirms that the original proxy statement complies with applicable law and that the supplemental disclosures are not an admission of legal necessity or materiality.
  • The company cautions that forward-looking statements are subject to risks and uncertainties, and actual results may differ materially.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While the document addresses stockholder concerns, it also reaffirms the company's position and provides additional information to support the merger. The cautionary language tempers any strong positive outlook.

Positives

  • Ansys is proactively addressing stockholder concerns to ensure transparency and avoid potential litigation.
  • The supplemental disclosures provide additional clarity on key aspects of the merger, such as executive employment and financial analysis.
  • The inclusion of Dr. Gopal on the Synopsys board could provide continuity and insight during the integration process.

Negatives

  • The stockholder demands suggest potential dissatisfaction or concerns regarding the initial disclosures.
  • The need for supplemental disclosures, even if voluntary, could indicate areas where the original proxy statement was perceived as lacking.
  • The cautionary language regarding forward-looking statements highlights the inherent risks and uncertainties associated with the merger.

Risks

  • The completion of the proposed transaction is subject to shareholder and regulatory approvals, as well as other conditions.
  • Failure to realize the anticipated benefits of the merger, including integration challenges, could negatively impact the combined company.
  • Potential litigation related to the merger could create disruptions and expenses.
  • The ability to retain and hire key personnel is crucial for the success of the integration.
  • Changes in legislative, regulatory, or economic conditions could affect the businesses of Ansys and Synopsys.
  • Failure to receive the approval of the stockholders of Ansys is a risk.

Future Outlook

The document contains forward-looking statements regarding the expected closing date of the proposed transaction and its potential benefits, but cautions that these statements are subject to risks and uncertainties.

Management Comments

  • Ansys believes that the allegations in the Demand Letters are without merit.
  • Ansys denies that it has violated any laws or breached any duties to Ansys stockholders.
  • Ansys believes that no supplemental disclosure to the Proxy Statement was or is required under any applicable law, rule or regulation.

Industry Context

The document references comparable transactions in the technology sector, providing context for the valuation of Ansys in the merger with Synopsys. These transactions include acquisitions of companies like Mentor Graphics, Inovalon, and Mimecast, offering benchmarks for enterprise value and financial multiples.

Comparison to Industry Standards

  • The document provides a table of comparable transactions, including companies like Mentor Graphics (acquired by Siemens), Inovalon (acquired by Nordic Capital), and Mimecast (acquired by Permira Holdings Limited).
  • The table includes the Fully Diluted (FD) Enterprise Value and Next Twelve Months (NTM) Levered Free Cash Flow (LFCF) Multiple for each transaction.
  • For example, the Mentor Graphics acquisition had an FD Enterprise Value of $4,521 million and an NTM LFCF Multiple of 46.6x, while the Inovalon acquisition had an FD Enterprise Value of $7,209 million and an NTM LFCF Multiple of 41.5x.
  • These comparables provide a basis for assessing the financial terms of the Ansys-Synopsys merger relative to other deals in the software and technology industries.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Synopsys Board of Directors MemberTBDDr. Ajei GopalEffective Time of MergerMutual agreement between Synopsys and Ansys, subject to completion of Synopsys director nomination process and satisfaction of all applicable eligibility requirements.

Legal Proceedings

  • Ansys has received fourteen demand letters from purported Company stockholders challenging the adequacy of certain disclosures made in the Proxy Statement.

Stakeholder Impact

  • Shareholders will receive additional information to inform their vote on the merger.
  • Employees face uncertainty regarding their roles and responsibilities post-merger.
  • Customers may experience changes in product offerings and support.
  • The merger could impact relationships with suppliers and other business partners.

Next Steps

  • Ansys stockholders will vote on the proposed merger.
  • Regulatory approvals must be obtained.
  • Synopsys will need to complete its director nomination process for Dr. Gopal.
  • The integration of Ansys and Synopsys will proceed upon completion of the merger.

Key Dates

DateDescription
January 15, 2024Ansys and Synopsys entered into an Agreement and Plan of Merger.
February 16, 2024Synopsys proxy statement for its 2024 Annual Meeting of Stockholders on Schedule 14A filed with the SEC.
March 19, 2024Synopsys and Ansys mutually agreed to designate Dr. Ajei Gopal to become a member of the Synopsys board of directors at the effective time.
April 10, 2024Ansys proxy statement for its 2024 Annual Meeting of Stockholders on Schedule 14A filed with the SEC.
April 17, 2024The SEC declared effective a registration statement on Form S-4 that included a prospectus with respect to the shares of common stock of Synopsys to be issued in the proposed transaction and a proxy statement of Ansys.
May 13, 2024Date of report (Date of earliest event reported).

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.